TXMD Earnings

Quarterly EPS
$0.02
Q4 2024
$-0.06
Q1 2025
$0.05
Q2 2025
$0.01
Q3 2025
$-0.05
Q4 2025
$0.01
Q1 2026
$0.01
Q2 2026
$0.04
Q3 2026
Latest Revenue1.3M
Latest Net Income491.0K
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026$0.041.3M491.0K+60.6%+300.0%
Q2 2026$0.01869.0K155.0K-8.7%-80.0%
Q1 2026$0.01724.0K95.0K+84.2%+116.7%
Q4 2025-$0.05893.0K-619000+33.9%-350.0%
Q3 2025$0.01784.0K152.0K+43.3%+120.0%
Q2 2025$0.05952.0K551.0K+306.8%+155.6%
Q1 2025-$0.06393.0K-653000+25.6%+0.0%
Q4 2024$0.02667.0K252.0K+32.9%+125.0%
Q3 2024-$0.05547.0K-609000——
Q2 2024-$0.09234.0K-1090000——
Q1 2024-$0.06313.0K-734000——
Q4 2023-$0.08502.0K-883000——
TherapeuticsMD (TXMD) — Earnings